期刊文献+

小剂量醛氢叶酸、氟尿嘧啶与顺铂联合治疗晚期胃肠道癌近期疗效 被引量:6

Immediate response of advanced gastrointestinal cancers treated with low dose of leucovorin (LDCF)、5 Fu and PDD
暂未订购
导出
摘要 目的:探讨小剂量醛氢叶酸(LDCF)、氟尿嘧啶(5Fu)与顺铂(PDD)三药联用治疗晚期胃肠道癌的临床疗效。方法:34例中胃癌16例,结直肠癌18例。CF30mg/日,静滴2小时,5Fu1.0/日,于CF滴完后立即静滴,维持8~12小时,连用5天;PDD40mg/日静滴,连用3天。结果:总有效率(CR+PR)52.9%,胃癌与结直肠癌的有效率分别为56.3%、50.0%。既往用过含5Fu方案的患者仍然有效(38.9%)。主要毒副反应为静脉炎、口腔炎、食欲下降、恶心呕吐、骨髓抑制,多为Ⅰ~Ⅱ级,大部分病人能耐受。结论:作者认为该方案毒性较低、疗效好。 Objective: To study the immediate response of advanced gastrointestinal cancer treated with low dose of leucovorin (LDCF)、 5 Fu and PDD. Methods: Low dose of leucovorin (LDCF)、5 Fu and PDD therapy were used in 34 histologically proven advanced gastrointestinal cancer patients, among which 16 cases were gastric cancer, 18 were colonic cancer. LDCF 30 mg/day iv in 2h; 5 Fu 1.0/day iv was given during 8~12h immediately when LDCF was over. They were repeated for 5 days, while PDD 40 mg/day was given iv through another venous for 3 days. Results: Total effective rate (CR+PR) was 52.9%. The effective rate for gastric and colonic cancers were 56.3% and 50.0%. Those who had been treated with 5 Fu previously were still effective (38.9%). Among side effects, phlebitis was most common seen. The other symptoms were gastrointestinal reaction and leukemia. Most were grade Ⅰ~Ⅱ which were tolerable for the patients. Conclusion: Uses of LDCF、5 Fu and PDD in advanced gastrointestinal cancers is worthwhile of further study.
作者 何流 吴罕莉
出处 《癌症》 SCIE CAS CSCD 北大核心 1998年第6期462-464,共3页 Chinese Journal of Cancer
关键词 胃肠肿瘤 药物疗法 醛氢叶酸 氟尿嘧啶 顺铂 Gastrointestinal neoplasms/drug therapy Fluorouracil/therapeutic use Cisplatin/therapeutic use
  • 相关文献

参考文献6

二级参考文献1

共引文献112

同被引文献14

  • 1张天惠,陈焰,杨宏凯.LF及ELF方案治疗晚期大肠癌22例近期疗效分析[J].癌症,1995,14(3):206-207. 被引量:7
  • 2毛雪华,何勇,范南峰,许凌.中量醛氢叶酸和5-FU联合治疗胃肠道肿瘤[J].新消化病学杂志,1996,4(12):687-688. 被引量:6
  • 3陆建伟 黄富麟 等.含羟基喜树碱联合治疗方案治疗晚期胃肠道癌临床观察[J].中国肿瘤临床(羟基喜树碱临床应用专辑),1997,32.
  • 4de Gramont A, Vignoud J, Tournigand C, et al. Oxaliplatin with high dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer [J]. Eur J Concer,1997, 33(2): 214-219.
  • 5Maindrnult G F, de Gramont A, Louvet C, et al. Evaluation of oxalipltin dose intensity in bimonthly leucovorin and 48 hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreat edmetastaticcolorectal cancet[J]. Oncology Multidisciplinary Resear
  • 6Andre T, Bensmaine M A, Louvet C, et al. Multicenter, phase Ⅱ study of bimonthly high-dose leucovorin, fluorouracil infudion,and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen[J]. Clin Oncol, 1999,
  • 7Sobrero A F, Aschele C, Bertino J R. Fluorouracil in colorectal cancer: A tale of two druga.Implications for biochemical modulation[J].J Clin Oncol, 1997, 15(1): 368-381.
  • 8Machover D. Treatment of advanced colorectal and gastric adenocarinomas with 5-Fluorouracil and high-dose folinicacid [J]. Clin Onco1,1986,4(4):685.
  • 9Raymond E, Faivre S, Woynarowski J M, et al. Oxaliplatin: mechanism of action and antineoplastic activity[J]. Semin Oncol, 1998, 25(2:Suppl 5):4-12.
  • 10Koizumi W,Kuriharanl M,Sasai T,et al. A phase study of com bination therapy with 5'-deoxy 5-fluorouridine and cisplatine in the treatment of advanced gastric cancer with primary fori. Cancer, 1993,72 (2): 658.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部